161 related articles for article (PubMed ID: 38284154)
1. Short- and Long-Term Effects on Glucose Control of Nonadherence to Insulin Therapy in People With Type 2 Diabetes An
Visentin R; Cobelli C; Sieber J; Dalla Man C
J Diabetes Sci Technol; 2024 Mar; 18(2):309-317. PubMed ID: 38284154
[TBL] [Abstract][Full Text] [Related]
2. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
[TBL] [Abstract][Full Text] [Related]
3. The Padova Type 2 Diabetes Simulator from Triple-Tracer Single-Meal Studies:
Visentin R; Cobelli C; Dalla Man C
Diabetes Technol Ther; 2020 Dec; 22(12):892-903. PubMed ID: 32324063
[No Abstract] [Full Text] [Related]
4. Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].
Cavan DA; Ziegler R; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Wagner RS
BMC Fam Pract; 2012 Oct; 13():102. PubMed ID: 23062116
[TBL] [Abstract][Full Text] [Related]
5. Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies.
Visentin R; Schiavon M; Giegerich C; Klabunde T; Man CD; Cobelli C
IEEE Trans Biomed Eng; 2019 Oct; 66(10):2889-2896. PubMed ID: 30735983
[TBL] [Abstract][Full Text] [Related]
6. Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations.
Visentin R; Schiavon M; Bonet J; Riz M; Wagenhuber B; Man CD
IEEE Trans Biomed Eng; 2024 Jun; 71(6):1780-1788. PubMed ID: 38198258
[TBL] [Abstract][Full Text] [Related]
7. Method for automatic adjustment of an insulin bolus calculator: in silico robustness evaluation under intra-day variability.
Herrero P; Pesl P; Bondia J; Reddy M; Oliver N; Georgiou P; Toumazou C
Comput Methods Programs Biomed; 2015 Apr; 119(1):1-8. PubMed ID: 25733405
[TBL] [Abstract][Full Text] [Related]
8. Classification of Postprandial Glycemic Status with Application to Insulin Dosing in Type 1 Diabetes-An In Silico Proof-of-Concept.
Cappon G; Facchinetti A; Sparacino G; Georgiou P; Herrero P
Sensors (Basel); 2019 Jul; 19(14):. PubMed ID: 31323886
[TBL] [Abstract][Full Text] [Related]
9. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
[TBL] [Abstract][Full Text] [Related]
10. Analyzing the Potential of Advanced Insulin Dosing Strategies in Patients With Type 2 Diabetes: Results From a Hybrid In Silico Study.
Reiterer F; Reiter M; Del Re L; Bechmann Christensen M; Nørgaard K
J Diabetes Sci Technol; 2018 Sep; 12(5):1029-1040. PubMed ID: 29681172
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
12. Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes.
Aronson R; Mahoney E; Saliu D; Sze D; Morel D; Bergquist L; Hirsch L
Diabetes Technol Ther; 2020 May; 22(5):352-359. PubMed ID: 31692373
[No Abstract] [Full Text] [Related]
13. [Effectiveness of selected methods of the short-term intensive insulin therapy in patients with poorly controlled type 2 diabetes mellitus].
Ruxer J; Mozdzan M; Czupryniak L; Saryusz-Wolska M; Loba J
Pol Arch Med Wewn; 2004 Aug; 112(2):945-52. PubMed ID: 15675270
[TBL] [Abstract][Full Text] [Related]
14. A software interface for in silico testing of type 2 diabetes treatments.
Visentin R; Cobelli C; Dalla Man C
Comput Methods Programs Biomed; 2022 Aug; 223():106973. PubMed ID: 35792365
[TBL] [Abstract][Full Text] [Related]
15. In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support
Visentin R; Schiavon M; Man CD
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():5111-5114. PubMed ID: 33019136
[TBL] [Abstract][Full Text] [Related]
16. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
[TBL] [Abstract][Full Text] [Related]
17. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
[TBL] [Abstract][Full Text] [Related]
18.
Schiavon M; Visentin R; Giegerich C; Sieber J; Dalla Man C; Cobelli C; Klabunde T
Diabetes Technol Ther; 2020 Aug; 22(8):553-561. PubMed ID: 32125178
[No Abstract] [Full Text] [Related]
19. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
20. OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R; Cohen O; Conget I; Runzis S; Castaneda J; de Portu S; Lee S; Reznik Y;
Diabetes Technol Ther; 2014 Jul; 16(7):414-20. PubMed ID: 24735134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
